Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Rivanicline is an agonist of α4β2 subunit-containing nicotinic acetylcholine receptors (nAChRs).1 It selectively induces rubidium ion efflux in M10 cells expressing α4β2 subunit-containing nAChRs (EC50 = 0.73 µM for the chicken channels) over M10 cells expressing α3β4- or α1β1γδ subunit-containing nAChRs (EC50s = >1,000 nM for both for the chicken channels) and a panel of 34 receptors, ion channels, and kinases at 10 µM. It induces contractions in isolated guinea pig ileum (EC30 = 15 µM). Rivanicline (0.6 µmol/kg) prevents scopolamine-induced memory deficits in the passive avoidance test in mice.2 It decreases the number of errors in the radial arm maze in a rat model of ibotenic acid-induced memory impairment when administered at doses of 0.3, 0.6 or 1.2 µmol/kg.
WARNING This product is not for human or veterinary use.
1. RJR-
2. RJR-